These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 410415)

  • 1. Tryptophan uptake by Mycobacterium tuberculosis H37Rv--inhibition by isoniazid.
    Sundaram KS; Venkitasubramanian TA
    Biochem Biophys Res Commun; 1977 Sep; 78(2):839-45. PubMed ID: 410415
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between the uptake of isoniazid and its action on in vivo mycolic acid synthesis in Mycobacterium tuberculosis.
    Wang L; Takayama K
    Antimicrob Agents Chemother; 1972 Dec; 2(6):438-41. PubMed ID: 4207759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective action of isoniazid on the synthesis of cell wall mycolates in mycobacteria.
    Takayama K
    Ann N Y Acad Sci; 1974 May; 235(0):426-38. PubMed ID: 4212333
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of isoniazid on mycolic acid synthesis in Mycobacterium tuberculosis and on its cell envelope.
    Winder FG; Collins P; Rooney SA
    Biochem J; 1970 Apr; 117(2):27P. PubMed ID: 4986870
    [No Abstract]   [Full Text] [Related]  

  • 5. IQG-607 abrogates the synthesis of mycolic acids and displays intracellular activity against Mycobacterium tuberculosis in infected macrophages.
    Rodrigues-Junior VS; dos Santos Junior AA; Villela AD; Belardinelli JM; Morbidoni HR; Basso LA; Campos MM; Santos DS
    Int J Antimicrob Agents; 2014 Jan; 43(1):82-5. PubMed ID: 24139881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid inhibition of the synthesis of monounsaturated long-chain fatty acids in Mycobacterium tuberculosis H37Ra.
    Davidson LA; Takayama K
    Antimicrob Agents Chemother; 1979 Jul; 16(1):104-5. PubMed ID: 112917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis.
    Takayama K; Wang L; David HL
    Antimicrob Agents Chemother; 1972 Jul; 2(1):29-35. PubMed ID: 4208567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptophan uptake by Mycobacterium tuberculosis H37Rv: effect of rifampin and ethambutol.
    Sundaram KS; Venkitasubramanian TA
    Antimicrob Agents Chemother; 1978 May; 13(5):726-30. PubMed ID: 96733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis.
    Takayama K; Schnoes HK; Armstrong EL; Boyle RW
    J Lipid Res; 1975 Jul; 16(4):308-17. PubMed ID: 806645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of mycolate synthetase activity in Mycobacterium tuberculosis exposed to isoniazid.
    Takayama K; Armstrong EL; David HL
    Am Rev Respir Dis; 1974 Jul; 110(1):43-8. PubMed ID: 4209359
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of the primary target for isoniazid in mycobacterial mycolic acid biosynthesis with Mycobacterium aurum A+.
    Wheeler PR; Anderson PM
    Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):451-7. PubMed ID: 8809032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical Genetic Interaction Profiling Reveals Determinants of Intrinsic Antibiotic Resistance in Mycobacterium tuberculosis.
    Xu W; DeJesus MA; Rücker N; Engelhart CA; Wright MG; Healy C; Lin K; Wang R; Park SW; Ioerger TR; Schnappinger D; Ehrt S
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The methyl-branched fortifications of Mycobacterium tuberculosis.
    Minnikin DE; Kremer L; Dover LG; Besra GS
    Chem Biol; 2002 May; 9(5):545-53. PubMed ID: 12031661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of isoniazid resistance in Mycobacterium tuberculosis H37Rv.
    Sriprakash KS; Ramakrishnan T
    Indian J Biochem; 1968 Dec; 5(4):185-7. PubMed ID: 4239955
    [No Abstract]   [Full Text] [Related]  

  • 15. Recycling and refurbishing old antitubercular drugs: the encouraging case of inhibitors of mycolic acid biosynthesis.
    Belardinelli JM; Morbidoni HR
    Expert Rev Anti Infect Ther; 2013 Apr; 11(4):429-40. PubMed ID: 23566152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of isoniazid on the carbohydrate metabolism of isoniazid-susceptible and isoniazid-resistant Mycobacterium tuberculosis H37Rv.
    Murthy PS; Sirsi M; Ramakrishnan T
    Am Rev Respir Dis; 1973 Jan; 107(1):139-41. PubMed ID: 4630310
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biosynthesis and regulation of mycolic acids in Mycobacterium tuberculosis--a review].
    Luo H; Pang L; Xie J
    Wei Sheng Wu Xue Bao; 2012 Feb; 52(2):146-51. PubMed ID: 22586991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.
    Parrish NM; Houston T; Jones PB; Townsend C; Dick JD
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1143-50. PubMed ID: 11257028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Effect of DFC-2 on Mycolic Acid Biosynthesis in
    Kim S; Seo H; Mahmud HA; Islam MI; Kim YS; Lyu J; Nam KW; Lee BE; Lee KI; Song HY
    J Microbiol Biotechnol; 2017 Nov; 27(11):1932-1941. PubMed ID: 28870005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between nicotinamide adenine dinucleotide concentration and antibacterial activity of isoniazid in Mycobacterium tuberculosis.
    Jackett PS; Aber VR; Mitchison DA
    Am Rev Respir Dis; 1977 Apr; 115(4):601-7. PubMed ID: 192114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.